A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)

Clinical trial NCT02196324 · COMPLETED

Trial details

NCT number: NCT02196324
Sponsor: Vyne Therapeutics Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prurigo Nodularis

Start date: 2014-07-09
Primary completion: 2016-05-27
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.